Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The NIHR TCC scheme have launched round 7 of the NIHR Clinical Trials Fellowships today.

NIHR Clinical Trials Fellowships are designed to support existing NIHR Trainees with an interest in, and experience of, working with clinical trials as part of their current training award who would benefit from further training within the setting of a Clinical Trials Unit (CTU) that is in receipt of NIHR CTU Support Funding, OCTRU is one of the eligible CTUs.

The training programme aims to expose the trainee to all aspects/stages of trials.

Applications are submitted jointly by the CTU and the trainee. All applicants must contact the CTU where they are interested in working prior to an application being submitted, stating their name and contact details, their current NIHR award and projected end date, summary of their trials exposure to date and reasons for applying. 

All applicants must have contacted the relevant CTU by Wednesday 11th July 2018 and applications must be submitted by 13:00 on Thursday 23rd August 2018

Further information can be found here:

https://www.nihr.ac.uk/funding-and-support/funding-for-training-and-career-development/training-programmes/clinical-trials-fellowships.htm 

Similar stories

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.